A novel nasal mucosal peptide-modified co-delivery system for ginsenoside Rg1, Rb1, and notoginseng saponin R1 in the amelioration of AD
Open Access
- 12 May 2026
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Abstract
The drug delivery for Alzheimer’s disease (AD) faces substantial obstacles owing to the presence of the blood-brain barrier (BBB). This circumstanceKeywords
Funding Information
- National Innovation and Entrepreneurship Training Program for Undergraduate (202510315035)
- National Natural Science Foundation of China (82304729)
- National Natural Science Foundation of China (82574587)
- Natural Science Foundation of Jiangsu Province (BK20230457)
- Scientific Research Foundation of Nanjing University of Chinese Medicine (ZYXYL2024-005)
This publication has 46 references indexed in Scilit:
- Preparation of pH-sensitive chitosan-deoxycholic acid-sodium alginate nanoparticles loaded with ginsenoside Rb1 and its controlled release mechanismInternational Journal of Biological Macromolecules, 2023
- Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease TherapySmall, 2022
- Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s diseaseAgeing Research Reviews, 2022
- Nanoparticles modified by polydopamine: Working as “drug” carriersBioactive Materials, 2020
- Intranasal delivery of paeoniflorin nanocrystals for brain targetingAsian Journal of Pharmaceutical Sciences, 2020
- Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in miceBrain, Behavior, and Immunity, 2016
- Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptidesActa Pharmaceutica Sinica B, 2016
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s diseaseActa Neuropathologica, 2009
- Thiolated chitosan microparticles: A vehicle for nasal peptide drug deliveryInternational Journal of Pharmaceutics, 2006
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988